506 related articles for article (PubMed ID: 30451017)
1. A characterization and disproportionality analysis of medication error related adverse events reported to the FAERS database.
Carnovale C; Mazhar F; Pozzi M; Gentili M; Clementi E; Radice S
Expert Opin Drug Saf; 2018 Dec; 17(12):1161-1169. PubMed ID: 30451017
[TBL] [Abstract][Full Text] [Related]
2. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study.
Phan M; Cheng C; Dang V; Wu E; Muñoz MA
Ther Innov Regul Sci; 2023 Sep; 57(5):1062-1073. PubMed ID: 37351842
[TBL] [Abstract][Full Text] [Related]
4. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
5. Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.
Star K; Norén GN; Nordin K; Edwards IR
Drug Saf; 2011 May; 34(5):415-28. PubMed ID: 21513364
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous reports of vaccination errors in the European regulatory database EudraVigilance: A descriptive study.
Hoeve CE; van Haren A; Sturkenboom MCJM; Straus SMJM
Vaccine; 2018 Dec; 36(52):7956-7964. PubMed ID: 30416019
[TBL] [Abstract][Full Text] [Related]
7. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.
Antonazzo IC; Raschi E; Forcesi E; Riise T; Bjornevik K; Baldin E; De Ponti F; Poluzzi E
Expert Opin Drug Saf; 2018 Sep; 17(9):869-874. PubMed ID: 30058390
[TBL] [Abstract][Full Text] [Related]
10. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
Kunac DL; Tatley MV
Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
[TBL] [Abstract][Full Text] [Related]
11. Real-world safety of Levetiracetam: Mining and analysis of its adverse drug reactions based on FAERS database.
He Z; Liu C; Lin L; Feng G; Wu G
Seizure; 2024 Apr; 117():253-260. PubMed ID: 38537425
[TBL] [Abstract][Full Text] [Related]
12. Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System.
Pera V; van Vaerenbergh F; Kors JA; van Mulligen EM; Parry R; de Wilde M; Lahousse L; van der Lei J; Rijnbeek PR; Verhamme KMC
Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5743. PubMed ID: 38158381
[TBL] [Abstract][Full Text] [Related]
13. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
[TBL] [Abstract][Full Text] [Related]
14. Medication-related incidents in acute care hospitals among different age groups: An analysis of national patient safety report data.
Han JM; Heo KN; Kim AJ; Lee AY; Min S; Ah YM; Lee JY
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5819. PubMed ID: 38783417
[TBL] [Abstract][Full Text] [Related]
15. Pediatric medication error reports in Korea adverse event reporting system database, 1989-2012: comparing with adult reports.
Woo Y; Kim HE; Chung S; Park BJ
J Korean Med Sci; 2015 Apr; 30(4):371-7. PubMed ID: 25829803
[TBL] [Abstract][Full Text] [Related]
16. Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase
Vogel U; van Stekelenborg J; Dreyfus B; Garg A; Habib M; Hosain R; Wisniewski A
Drug Saf; 2020 Apr; 43(4):351-362. PubMed ID: 32020559
[TBL] [Abstract][Full Text] [Related]
17. Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database.
Yin G; Song G; Xue S; Liu F
Sci Rep; 2024 May; 14(1):11367. PubMed ID: 38762547
[TBL] [Abstract][Full Text] [Related]
18. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
[TBL] [Abstract][Full Text] [Related]
19. A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib.
Peng L; Xiao K; Ottaviani S; Stebbing J; Wang YJ
Expert Opin Drug Saf; 2020 Nov; 19(11):1505-1511. PubMed ID: 32693646
[TBL] [Abstract][Full Text] [Related]
20. Medication errors in pediatric inpatients: a study based on a national mandatory reporting system.
Rishoej RM; Almarsdóttir AB; Christesen HT; Hallas J; Kjeldsen LJ
Eur J Pediatr; 2017 Dec; 176(12):1697-1705. PubMed ID: 28965285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
